Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020

SELL
$2.48 - $8.1 $1.6 Million - $5.21 Million
-643,151 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$10.05 - $14.25 $145,312 - $206,040
14,459 Added 2.3%
643,151 $7.27 Million
Q1 2019

May 14, 2019

BUY
$11.82 - $14.48 $756,480 - $926,720
64,000 Added 11.33%
628,692 $8.04 Million
Q3 2018

Nov 14, 2018

BUY
$10.92 - $18.18 $289,827 - $482,515
26,541 Added 4.93%
564,692 $10.2 Million
Q2 2018

Aug 13, 2018

BUY
$10.0 - $17.87 $2.49 Million - $4.44 Million
248,644 Added 85.89%
538,151 $8.15 Million
Q1 2018

May 15, 2018

BUY
$9.36 - $15.22 $731,016 - $1.19 Million
78,100 Added 36.94%
289,507 $3.91 Million
Q4 2017

Feb 13, 2018

SELL
$8.48 - $12.0 $12,075 - $17,088
-1,424 Reduced 0.67%
211,407 $2.06 Million
Q3 2017

Nov 14, 2017

BUY
$6.38 - $8.14 $1.36 Million - $1.73 Million
212,831
212,831 $1.73 Million

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.